Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

43.10 USD -2.65 (-5.79%)
Official Closing Price Updated: 7:58 PM EDT, Sep 18, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
10 Biggest Price Target Changes For Thursday
Needham lifted the price target on Thermo Fisher Scientific Inc. (NYSE: TMO) from $468 to $477. Thermo Fisher Scientific shares ... 
Tags Price Target PCTY Price Target Changes
From Benzinga
62 Biggest Movers From Yesterday
Gainers Snowflake Inc. (NYSE: SNOW) shares surged 111.6% to close at $253.93 on Wednesday after the company priced its IPO at $120 ... 
Tags Top Gainers POLA IPOB
From Benzinga
Noteworthy Wednesday Option Activity: LASR, ARWR, SGRY
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in nLight Inc (LASR), where a total volume of 5,061 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Dow Jumps 300 Points; Fed Leaves Interest Rates Unchanged
Toward the end of trading Wednesday, the Dow traded up 1.1% to 28302.78 while the NASDAQ rose 0.06% to 11196.87. The S&P also rose, ... 
Tags Markets Eurozone Intraday Update
From Benzinga
Stocks Gain Steam Ahead of Powell Speech
The Dow and S&P 500 are on track for their fourth-straight wins. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Arrowhead Pharma Reveals Positive Data On Drug To Treat Liver Disease; ARWR Stock Jumps
Arrowhead Pharma posted positive clinical trials data on a promising drug to treat a rare genetic liver disease, and ARWR stock soared near a nine-moth high; shares of rival Dicerna also jumped. 
From Investor's Business Daily
42 Stocks Moving In Wednesday's Mid-Day Session
Gainers Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) surged 47.3% to $49.77 after the company announced positive interim 24-week ... 
Tags EB XELA Markets
From Benzinga
Mid-Day Market Update: Crude Oil Surges 4%; Eastman Kodak Shares Spike Higher
Midway through trading Wednesday, the Dow traded up 0.77% to 28,207.22 while the NASDAQ fell 0.05% to 11,184.63. The S&P also rose, ... 
Tags Mid/Day Market Update NVUS ADT
From Benzinga
Why Arrowhead Pharma's Stock Is Trading Higher Today
Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares are trading higher on Wednesday after the company announced positive interim 24-week ... 
Tags Market News Health Care General
From Benzinga
Looking Into Arrowhead Pharmaceuticals's Return On Capital Employed
Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q3 sales of $27.38 million. Earnings fell to a loss of $15.95 million, resulting in a ... 
Tags General Benzinga Earnings
From Benzinga
Mid-Morning Market Update: Markets Open Higher; FedEx Tops Q1 Expectations
Following the market opening Wednesday, the Dow traded up 0.42% to 28111.93 while the NASDAQ rose 0.03% to 11193.23. The S&P also ... 
Tags Markets Eurozone CLIR
From Benzinga
Thinking about trading options or stock in Arrowhead Pharmaceuticals, United Parcel Service, MGM Resorts, Moderna, or Microsoft?
InvestorsObserver issues critical PriceWatch Alerts for ARWR, UPS, MGM, MRNA, and MSFT. 
From PR Newswire
Arrowhead ARO-AAT Phase 2 Interim Results in Patients with Alpha-1 Liver Disease Demonstrate Improvements in Key Parameters after Six Months of Treatment
Arrowhead positive interim 24-week liver biopsy clinical trial results for ARO-AAT in alpha-1 antitrypsin deficiency improves Key Parameters 
From Business Wire News Releases
Arrowhead Pharmaceuticals Appoints Oye Olukotun to Board of Directors
Arrowhead appoints veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company 
From Business Wire News Releases
Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences
Arrowhead Pharmaceuticals to present at multiple investor conferences in September 2020 
From Business Wire News Releases
Arrowhead Presents Positive New Phase 1/2 Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at European Society of Cardiology Congress 2020
Arrowhead Pharmaceuticals positive new Phase 1/2 clinical data on two RNAi-based cardiometabolic candidates ARO-APOC3 and ARO-ANG3 at ESC Congress 
From Business Wire News Releases
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended August 28 amid thin news flow. Barring updates on coronavirus vaccine/treatment candidates, there was very little for the sector to... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Biotech stocks went about a consolidation move in the week ended Aug. 28 amid thin news flow. Barringupdates on coronavirus ... 
Tags ARWR CSTL AMRN
From Benzinga
The Daily Biotech Pulse: Moderna Japanese Vaccine Deal Talk, Lipocine FDA Decision, Liver Congress Presentations
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 27) Abbott Laboratories (NYSE: ABT)( announced emergency use ... 
Tags Offerings ODT Biotech
From Benzinga
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver Congress
Arrowhead and Janssen present Phase clinical data on hepatitis B treatment JNJ-3989 at EASL International Liver Congress 2020 
From Business Wire News Releases
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
After seeing strength earlier, biotech stocks came under pressure in the past week. With the earnings season tapering and not much noise on the coronavirus front, the sector reacted to clinical... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering ... 
Tags ALVR ASMB MYOK
From Benzinga
Arrowhead Pharmaceuticals to Participate in Upcoming August 2020 Conferences
Arrowhead Pharmaceuticals to present at August 2020 conferences 
From Business Wire News Releases
Arrowhead Pharmaceuticals Initiates Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
Arrowhead dosed the first patient in a clinical trial of RNAi based ARO-HIF2 for treatment of renal cell carcinoma 
From Business Wire News Releases
IBD Rating Upgrades: Arrowhead Pharma Shows Improved Relative Price Strength
Arrowhead Pharma shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Stocks Generating Improved Relative Strength: Arrowhead Pharma
A Relative Strength Rating upgrade for Arrowhead Pharma shows improving technical performance. Will it continue? 
From Investor's Business Daily
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis 
From Business Wire News Releases
Notable Friday Option Activity: CSCO, ARWR, APPN
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cisco Systems Inc (CSCO), where a total volume of 86,463 contracts has been traded... 
Tags Stocks
From Market News Video
Arrowhead Pharmaceuticals, Inc (ARWR) Q3 2020 Earnings Call Transcript
ARWR earnings call for the period ending June 30, 2020. 
Tags Market News ARWR
From Motley Fool
Arrowhead Pharmaceuticals Reports Fiscal 2020 Third Quarter Results
Arrowhead Pharmaceuticals reports fiscal Q3 2020 earnings results and hosts conference call 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.